Acurx Pharmaceuticals (ACXP)
1.57
0.00 (0.00%)
Upcoming Events
Latest Headlines
Acurx Pharmaceuticals (NASDAQ: ACXP) Highlights FDA's New CDI Guidance That Could Accelerate Approval Path for Ibezapolstat
May 19, 2026 12:26 PM - StreetInsider
Form 424B3 Acurx Pharmaceuticals,
May 12, 2026 3:05 PM - SEC Filing
Form 424B3 Acurx Pharmaceuticals,
May 12, 2026 3:04 PM - SEC Filing
Acurx Pharmaceuticals (ACXP) Misses Q1 EPS by 62c
May 12, 2026 8:44 AM - StreetInsider
Acurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update
May 12, 2026 7:01 AM - PR NewsWire
Form EFFECT Acurx Pharmaceuticals,
May 12, 2026 6:07 AM - SEC Filing
Form EFFECT Acurx Pharmaceuticals,
May 12, 2026 6:07 AM - SEC Filing
Form 10-Q Acurx Pharmaceuticals, For: Mar 31
May 11, 2026 4:07 PM - SEC Filing
Acurx Pharmaceuticals (ACXP) files for 1.3M share offering by selling stockholders
May 4, 2026 4:13 PM - StreetInsider
Form S-1 Acurx Pharmaceuticals,
May 4, 2026 4:10 PM - SEC Filing
Form S-1 Acurx Pharmaceuticals,
May 4, 2026 4:09 PM - SEC Filing
Acurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors' Microbiome Evaluation at ESCMID Global 2026
May 4, 2026 8:00 AM - PR NewsWire
Form D Acurx Pharmaceuticals,
April 29, 2026 4:19 PM - SEC Filing
Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
April 29, 2026 8:00 AM - PR NewsWire
Acurx Pharmaceuticals, Inc. To Present at The Market Movers Investor Summit
April 27, 2026 8:04 AM - StreetInsider
Form 4 Acurx Pharmaceuticals, For: Apr 20 Filed by: Sailer Carl
April 22, 2026 4:21 PM - SEC Filing
Form 4 Acurx Pharmaceuticals, For: Apr 20 Filed by: DEAN JACK H
April 22, 2026 4:21 PM - SEC Filing
Form 4 Acurx Pharmaceuticals, For: Apr 20 Filed by: Donohue James J.
April 22, 2026 4:20 PM - SEC Filing
Form 4 Acurx Pharmaceuticals, For: Apr 20 Filed by: HARRISON THOMAS L
April 22, 2026 4:20 PM - SEC Filing
Form 4 Acurx Pharmaceuticals, For: Apr 20 Filed by: Scodari Joseph C
April 22, 2026 4:20 PM - SEC Filing
Form 4 Acurx Pharmaceuticals, For: Apr 20 Filed by: DELUCCIA ROBERT J
April 22, 2026 4:20 PM - SEC Filing
Form 4 Acurx Pharmaceuticals, For: Apr 20 Filed by: LUCI DAVID P
April 22, 2026 4:18 PM - SEC Filing
Form 4 Acurx Pharmaceuticals, For: Apr 20 Filed by: Shawah Robert G.
April 22, 2026 4:17 PM - SEC Filing
Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update
April 20, 2026 8:00 AM - PR NewsWire
New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Gro
April 18, 2026 10:00 AM - StreetInsider
Acurx Pharmaceuticals closes $2.5M offering with potential $4.6M more
April 16, 2026 4:01 PM - StreetInsider
Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
April 16, 2026 4:01 PM - PR NewsWire
Form 8-K Acurx Pharmaceuticals, For: Apr 15
April 16, 2026 8:15 AM - SEC Filing
Form 424B5 Acurx Pharmaceuticals,
April 16, 2026 8:14 AM - SEC Filing
ACXP raises $2.5 million in direct offering with warrant potential
April 16, 2026 8:00 AM - StreetInsider
Acurx Pharmaceuticals raises $2.5 million in registered direct offering
April 16, 2026 8:00 AM - StreetInsider
Acurx Pharmaceuticals, Inc. Announces up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
April 16, 2026 8:00 AM - PR NewsWire
New to The Street Resigns Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) to Continue Long-Form Interview Series, Outdoor Media Campaigns and Accredited Investor Events
April 7, 2026 9:03 AM - StreetInsider
New to The Street Announces Episode 741 Airing Tonight on Bloomberg Television at 6:30 PM EST Featuring Canton Networks, Acme Markets, Virtuix Holdings (VTIX), HPB, Jonas & Redman, Acurx Pharmaceutica
April 4, 2026 10:05 AM - StreetInsider
Korean Patent Office Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
March 30, 2026 7:01 AM - PR NewsWire
New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)
March 28, 2026 11:00 AM - StreetInsider
Full Article List
